| n (%) |
Normal | 32 (64) | 45 (90) | 44 (88) | 40 (80) | 50 (100) |
Low | 0 | 3 (6) | 2 (4) | 7 (14) | (0) |
Abnormal (High) | 18 (36) | 2 (4) | 4 (8) | 3 (6) | (0) |
M±SD | 37.8±18.98 | 33.28±29.7 | 36.7±42.6 | 236.5 ± 76.9 | 3.12 ± 1.12 |
Liver Function Test (After VPA doses received) |
Normal Range | 28 (56) | 44 (88) | 36 (72) | 39 (78) | 50 (100) |
Low | 2 (4) | 4 (8) | 5 (10) | 9 (18) | 0 |
Abnormal (High) | 20 (40) | 2 (4) | 9 (18) | 2 (4) | 0 |
M±SD | 38±20.13 | 26.24±15.9 | 46.58±67.5 | 233±86.8 | 2.62±1.21 |
P-value Sig. (2-tailed) (comparison between each of subcategory of LFTs) | F(1.076)=0.435 | F(3.372)=0.002 | F(2.897)=0.013 | F(9.378)=0.002 | F(1.011)=0.423 |